Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

F-Prime Capital Partners

F-Prime Capital Partners
VC INVESTOR TYPE
Active STATUS
30 PROFESSIONALS
309 INVESTMENTS
134 PORTFOLIO
85 EXITS
Description

Founded in 1969, F-Prime Capital Partners is a venture capital investment firm that is based in Cambridge, Massachusetts. The firm prefers to invest in enterprise information technology, therapeutics, med-tech, healthcare service and fin-tech sectors.

Formerly Known As
Fidelity Biosciences
Investor Status
Actively Seeking New Investments
Trade Association
National Venture Capital Association (NVCA)
Year Founded
1969
Primary Investor Type
Venture Capital
Primary Office
  • 1 Main Street
  • 13th Floor
  • Cambridge, MA 02142
  • United States

+1 (617) 000-0000

F-Prime Capital Partners Investments (309)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
Funnel 17-Jan-2020 Later Stage VC 0000 Application Software Generating Revenue
00000 14-Jan-2020 00000 00000 0000 Other Healthcare Technology Systems Generating Revenue 000000000 0000000 00.0
0000000 0000000000 12-Dec-2019 00000 00000 000.00 Biotechnology Product Development 000 0000000
000000000 00000000 04-Dec-2019 00000 00000 000 Drug Discovery Clinical Trials - Phase 2 000000 0000 00
00000000 20-Nov-2019 00000 00000 00000 Medical Records Systems Generating Revenue
000000000 19-Nov-2019 00000 00000 0000 Other Healthcare Technology Systems Generating Revenue 0000 00000
000000 0000 000000 31-Oct-2019 00000 00000 0000 Consumer Finance Generating Revenue 00000 00000 00
00000000000 22-Oct-2019 00000 00000 00.000 Biotechnology Stealth
SnapDocs 10-Oct-2019 Later Stage VC 0000 Application Software Generating Revenue 00000 00000 00
Buoy Health 08-Oct-2019 Later Stage VC 0000 Other Healthcare Technology Systems Generating Revenue 0000 00000
To view this investor’s complete investment and acquisition history, request access »
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore F-Prime Capital Partners’s full profile, request a free trial.

F-Prime Capital Partners Exits (82)

Company Name Exit Date Exit Type Exit Size Status Buyers
Lumere 13-Jan-2020 Buyout/LBO Completed
  • 3 buyers
000000 000000000 24-Nov-2019 000000000000000000 000.00 Completed
  • 0000 00000
00000 000000000000 09-Sep-2019 000000000000000000 00000 Completed
  • 0000000
0000000 0000000 01-May-2019 000000000000000000 Completed
  • 0000000
000000000 00000000 28-Mar-2019 000 00000 Completed
0000000 07-Feb-2019 000000000000000000 00.00 Completed
  • 00000000 0000 0000
00000 08-Jan-2019 000000000000000000 00000 Completed
  • 00000 (000000000 0
00000000 000000000 31-Oct-2018 000 00000 Completed
  • 4 buyers
Orchard Therapeutics 31-Oct-2018 IPO 00000 Completed
Hua Medicine 14-Sep-2018 IPO 00000 Completed
To view this investor’s complete exits history, request access »

F-Prime Capital Partners Team (80)

Name Title Deals Funds Boards Office Contact
Info
Stacie Weninger Ph.D President, FBRI 0 0 Cambridge, MA
Mary Pendergast Partner & Chief Financial Officer Cambridge, MA
Jay Farber Venture Partner Cambridge, MA
John Vigeant Venture Partner Cambridge, MA
Mihir Shah Venture Partner Cambridge, MA

24 Former Team Members

You’re viewing 5 of 80 team members. Get the full list »

F-Prime Capital Partners Co-Investors (435)

Name With Exits Lead Partner
Eight Roads 52 0 00
ARCH Venture Partners 0 0 0
Maverick Ventures 0 0
Polaris Partners 0 0
OrbiMed 0 0 0
To view this investor’s complete co-investor history, request access »